Comgest Global Investors S.A.S. Increases Stock Holdings in Relx Plc (NYSE:RELX)

Comgest Global Investors S.A.S. boosted its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 30.8% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 55,284 shares of the technology company's stock after acquiring an additional 13,030 shares during the period. Comgest Global Investors S.A.S.'s holdings in Relx were worth $2,511,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. CENTRAL TRUST Co boosted its stake in Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after purchasing an additional 529 shares during the last quarter. Versant Capital Management Inc acquired a new position in Relx in the fourth quarter valued at about $31,000. Sierra Ocean LLC purchased a new stake in Relx in the fourth quarter valued at approximately $43,000. Brown Brothers Harriman & Co. lifted its stake in Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after acquiring an additional 662 shares in the last quarter. Finally, Private Trust Co. NA boosted its stake in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares during the period. 15.02% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on RELX. StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Redburn Atlantic started coverage on shares of Relx in a research note on Wednesday, January 8th. They set a "buy" rating on the stock. Morgan Stanley restated an "overweight" rating on shares of Relx in a research report on Wednesday. The Goldman Sachs Group initiated coverage on Relx in a report on Wednesday, March 26th. They set a "buy" rating on the stock. Finally, Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Buy".

Relx Price Performance

NYSE RELX traded up $1.00 during mid-day trading on Friday, hitting $52.20. The stock had a trading volume of 718,471 shares, compared to its average volume of 717,339. The company has a market cap of $96.61 billion, a price-to-earnings ratio of 28.06, a P/E/G ratio of 2.73 and a beta of 0.84. Relx Plc has a 52-week low of $40.25 and a 52-week high of $52.54. The company has a 50 day simple moving average of $49.35 and a 200 day simple moving average of $47.97. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46.

Relx Increases Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be issued a $0.5586 dividend. This represents a yield of 1.6%. This is a positive change from Relx's previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. Relx's dividend payout ratio is 59.68%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.